Medirom Common Stock vs Net Tangible Assets Analysis
MRM Stock | USD 5.26 0.22 4.01% |
Medirom Healthcare financial indicator trend analysis is infinitely more than just investigating Medirom Healthcare recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medirom Healthcare is a good investment. Please check the relationship between Medirom Healthcare Common Stock and its Net Tangible Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Common Stock vs Net Tangible Assets
Common Stock vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medirom Healthcare Common Stock account and Net Tangible Assets. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Medirom Healthcare's Common Stock and Net Tangible Assets is -0.58. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Medirom Healthcare Technologies, assuming nothing else is changed. The correlation between historical values of Medirom Healthcare's Common Stock and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Medirom Healthcare Technologies are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Common Stock i.e., Medirom Healthcare's Common Stock and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | -0.58 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Common Stock
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most indicators from Medirom Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medirom Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Medirom Healthcare's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 3rd of May 2024, Enterprise Value Over EBITDA is likely to grow to 27.41, while Tax Provision is likely to drop about 33.7 M.
2020 | 2021 | 2023 | 2024 (projected) | Gross Profit | 317.7M | 1.4B | 1.6B | 1.1B | Total Revenue | 1.4B | 5.4B | 6.2B | 4.3B |
Medirom Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Medirom Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medirom Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Long Term Debt | 150.5M | 668.4M | 746.6M | 1.1B | 1.3B | 672.8M | |
Capital Lease Obligations | 1.8B | 1.7B | 1.9B | 2.0B | 1.8B | 1.5B | |
Net Invested Capital | 1.1B | 1.3B | 700.5M | 1.2B | 1.4B | 1.1B | |
Property Plant And Equipment Gross | 2.0B | 183.1M | 2.4B | 2.6B | 3.0B | 2.1B | |
Short Long Term Debt | 371.6M | 221.1M | 162.3M | 99.2M | 89.3M | 84.8M | |
Non Current Liabilities Other | 5.6M | 348.4M | 25.2M | 335.0M | 385.2M | 404.5M | |
Net Working Capital | (884.0M) | 428.3M | (1.8B) | (1.3B) | (1.2B) | (1.2B) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medirom Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medirom Healthcare's short interest history, or implied volatility extrapolated from Medirom Healthcare options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Medirom Stock analysis
When running Medirom Healthcare's price analysis, check to measure Medirom Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medirom Healthcare is operating at the current time. Most of Medirom Healthcare's value examination focuses on studying past and present price action to predict the probability of Medirom Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medirom Healthcare's price. Additionally, you may evaluate how the addition of Medirom Healthcare to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Medirom Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.05) | Revenue Per Share 1.4 K | Quarterly Revenue Growth 0.03 | Return On Assets (0.01) | Return On Equity (7.00) |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.